KIYATEC KIYATEC has developed primary human derived 3D microtumors designed to more accurately predict human response to cancer drugs in an ex vivo system. The heterotypic, 3D perfused co-cultures established the use of a systemic strategy of adopting optimized...
JBS Science JBS Science Inc. is a discovery and development phase cancer diagnostic company focused on the delivery of urine based DNA tests for cancer screening and liquid biopsy for cancer precision medicine to improve disease management. The company’s mission...
Inanovate Inanovate has developed a patented blood analysis system for use in research and diagnostic applications. The system, called the Bio-ID, detects and quantifies the presence of disease related biological molecules (biomarkers) from patient samples, in one...
CloudMedx CloudMedx is a health technology company that focuses on streamlining clinical encounters and optimizing patient and financial outcomes through predictive analytics. The company utilizes evidence based algorithms, machine learning and natural language...
Cernostics Cernostics is focused on delivering next generation cancer diagnostics and prognostics through an innovative approach to tissue analysis – the evaluation of the tumor as a system composed of multiple interacting cell types, including tumor, immune, and...
PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.
View the top 3 talks from PMWC here (password: top-videos).
